Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Retained Earnings (2016 - 2025)

Orthofix Medical's Retained Earnings history spans 17 years, with the latest figure at -$368.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 33.39% year-over-year to -$368.3 million, compared with a TTM value of -$368.3 million through Dec 2025, down 33.39%, and an annual FY2025 reading of -$368.3 million, down 33.39% over the prior year.
  • Retained Earnings for Q4 2025 was -$368.3 million at Orthofix Medical, down from -$366.1 million in the prior quarter.
  • The five-year high for Retained Earnings was $56.0 million in Q2 2021, with the low at -$368.3 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$84.8 million, with a median of -$2.2 million recorded in 2023.
  • Year-over-year, Retained Earnings soared 545.76% in 2021 and then plummeted 13179.3% in 2024.
  • Tracing OFIX's Retained Earnings over 5 years: stood at $21.0 million in 2021, then crashed by 94.04% to $1.3 million in 2022, then plummeted by 12101.92% to -$150.1 million in 2023, then crashed by 83.92% to -$276.1 million in 2024, then crashed by 33.39% to -$368.3 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Retained Earnings are -$368.3 million (Q4 2025), -$366.1 million (Q3 2025), and $908000.0 (Q2 2025).